표제지
목차
국문초록 10
I. 서론 11
II. 연구대상 및 방법 13
1. 연구대상 13
1) 연구대상자 선정 13
2) 연구자료수집 15
2. 연구방법 16
1) 심장초음파검사 16
2) 심근효소검사(Cardiac enzymes test) 22
3) 허혈성심질환 진단 평가 24
4) 통계처리 25
III. 결과 26
1. 심장초음파지수와 심근효소 기초분석 26
1) 연령별 분석 26
2) 성별 분석 30
2. 심장초음파지수 분석 34
1) 좌심실구혈률(Ejection fraction) 분석 34
2) 국소벽운동이상(RWMA) 35
3. 심근효소 분석 36
1) CK(Creatine kinase) 36
2) CK-MB(Creatine kinase myocardial band) 37
3) cTnI(Cardiac specific troponin I) 38
4. 허혈성심질환 진단분석 39
5. 영향인자 간 교차분석 40
1) 국소벽운동이상과 심근효소의 교차분석 40
2) 허혈성심질환과 영향인자의 교차분석 43
6. 영향인자의 상관관계분석 45
7. 국소벽운동이상과 심근효소의 ROC분석 46
IV. 고찰 48
V. 결론 52
참고문헌 54
ABSTRACT 60
Table 1. The plan of study members by age and sex distribution 14
Table 2. List of echocardiography devices 16
Table 3. Reference value of cardiac enzymes 24
Table 4. Average of echocardiography measurements by age distribution 27
Table 5. Average of cardiac enzymes measurement by age distribution 28
Table 6. Average of echocardiography measurements by sex distribution(Male) 30
Table 7. Average of echocardiography measurement by sex distribution(Female) 31
Table 8. Average of cardiac enzymes measurement by sex distribution(Male) 32
Table 9. Average of cardiac enzymes measurement by sex distribution(Female) 33
Table 10. Left ventricular ejection fraction(EF) analysis of study members by age and sex distribution 34
Table 11. Regional wall motion abnormality(RWMA) analysis of study members by age and sex distribution 35
Table 12. Cardiac enzymes CK analysis of study members by age and sex distribution 36
Table 13. Cardiac enzymes CK-MB analysis of study members by age and sex distribution 37
Table 14. Cardiac enzymes cTnI analysis of study members by age and sex distribution 38
Table 15. Ischemic heart disease diagnosis analysis of study members by age and sex distribution 39
Table 16. Chi-square analysis of regional wall motion abnormality(RWMA)and cardiac enzymes 41
Table 17. Chi-square analysis of regional wall motion abnormality(RWMA)and cardiac enzymes(Male) 42
Table 18. Chi-square analysis of regional wall motion abnormality(RWMA)and cardiac enzymes(Female) 42
Table 19. Chi-square analysis of influential factor in Ischemic heart disease diagnosis 44
Table 20. Intersection of influential factor and Ischemic heart disease diagnosis 44
Table 21. Correlation analysis of influential factor and regional wall motion abnormality(RWMA) 45
Table 22. ROC Analysis of regional wall motion abnormality(RWMA) and cardiac enzymes 46
Fig. 1. Left ventricular ejection fraction measured by M-mode 17
Fig. 2. Left ventricular ejection fraction measured by Simpson's method 18
Fig. 3. Regional wall motion score index(WMSI) 21
Fig. 4. Immunization device cobas e411(Roche/Hitachi, Japan) 22
Fig. 5. Average of cardiac enzymes measurement by age distribution 29
Fig. 6. ROC Analysis of ischemic heart disease and regional wall motion abnormality(RWMA) 47
Fig. 7. ROC Analysis of ischemic heart disease and cardiac enzymes 47